30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Cardiff Oncology Inc (CRDF)

Track

In the last 90 days, Cardiff Oncology Inc. has seen net insider buying totaling $103,090.63, with two insiders making purchases. Notably, CEO Mani Mohindru acquired shares valued at $29,890.63. This activity occurred following a recent earnings report that missed expectations by 50%. The stock has experienced a 25.1% decline over the past 90 days.
Stock chart
Ticker: CRDF Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
PACE GARY W
2 purchases — total 200,000 USD
Buy 18 Jun 2026
Value US$137,966.87 | Price 481.48 | Shares 64,010
Buy 18 Jun 2026
Value US$3,929,875.17 | Price 17.61 | Shares 4,876
Buy 18 Jun 2026
Value US$2,119,882.62 | Price 190.22 | Shares 13,864
Buy 30 Jul 2025
Value US$36,750.00 | Price 2.45 | Shares 15,000
Buy 30 Jul 2025
Value US$673,750.00 | Price 2.45 | Shares 275,000
Buy 18 Dec 2024
Value US$12,000.00 | Price 5.00 | Shares 2,400
Buy 17 Dec 2024
Value US$14,905.38 | Price 5.42 | Shares 2,752
Buy 16 Dec 2024
Value US$9,820.12 | Price 3.83 | Shares 2,564
Buy 12 Dec 2024
Value US$34,224.00 | Price 3.42 | Shares 10,000
Buy 11 Dec 2024
Value US$29,900.00 | Price 2.60 | Shares 11,500
Buy 11 Dec 2024
Value US$910,299.00 | Price 2.60 | Shares 350,115
Buy 19 Dec 2023
Value US$41,100.00 | Price 1.37 | Shares 30,000
Buy 10 Nov 2023
Value US$22,491.00 | Price 0.98 | Shares 22,950
Buy 25 Nov 2022
Value US$14,300.00 | Price 1.43 | Shares 10,000
Buy 19 Sep 2022
Value US$24,525.00 | Price 1.64 | Shares 15,000
Buy 16 Sep 2022
Value US$20,233.20 | Price 1.56 | Shares 13,000
Buy 16 Sep 2022
Value US$46,710.00 | Price 1.56 | Shares 30,000
Buy 15 Sep 2022
Value US$6,192.00 | Price 1.72 | Shares 3,600
Buy 15 Sep 2022
Value US$10,976.00 | Price 1.72 | Shares 6,400
Buy 15 Sep 2022
Value US$256,500.00 | Price 1.71 | Shares 150,000
Buy 10 Sep 2021
Value US$31,600.00 | Price 6.32 | Shares 5,000
Buy 10 Sep 2021
Value US$31,750.00 | Price 6.35 | Shares 5,000
Buy 10 Sep 2021
Value US$63,800.00 | Price 6.38 | Shares 10,000
Buy 10 Sep 2021
Value US$33,750.00 | Price 6.75 | Shares 5,000
Buy 10 Sep 2021
Value US$33,100.00 | Price 6.62 | Shares 5,000
Buy 26 Mar 2021
Value US$29,933.22 | Price 10.32 | Shares 2,900
Buy 23 Mar 2021
Value US$25,775.00 | Price 10.31 | Shares 2,500
Buy 23 Mar 2021
Value US$25,525.00 | Price 10.21 | Shares 2,500
Buy 23 Mar 2021
Value US$51,000.00 | Price 10.20 | Shares 5,000
Buy 23 Mar 2021
Value US$9,979.74 | Price 10.34 | Shares 965
Buy 23 Mar 2021
Value US$4,885.65 | Price 10.40 | Shares 470
Buy 23 Mar 2021
Value US$19,803.70 | Price 10.42 | Shares 1,900
Buy 23 Mar 2021
Value US$9,897.60 | Price 10.31 | Shares 960
Buy 22 Mar 2021
Value US$32,850.00 | Price 10.95 | Shares 3,000
Buy 19 Mar 2021
Value US$43,271.20 | Price 10.82 | Shares 4,000
Buy 18 Mar 2021
Value US$21,080.00 | Price 10.54 | Shares 2,000
Buy 18 Mar 2021
Value US$10,580.00 | Price 10.58 | Shares 1,000
Buy 4 Mar 2021
Value US$13,897.50 | Price 9.27 | Shares 1,500
Sale 23 Nov 2020
Value US$657,020.05 | Price 18.60 | Shares 35,321
Buy 16 Sep 2020
Value US$4,853.50 | Price 5.71 | Shares 850
Buy 16 Sep 2020
Value US$9,673.00 | Price 5.69 | Shares 1,700
Buy 14 May 2020
Value US$25,000.69 | Price 1.43 | Shares 17,483
Buy 14 May 2020
Value US$29,999.97 | Price 1.43 | Shares 20,979
Buy 14 May 2020
Value US$99,999.90 | Price 1.43 | Shares 69,930
Buy 14 May 2020
Value US$19,999.98 | Price 1.43 | Shares 13,986
Buy 14 May 2020
Value US$9,999.99 | Price 1.43 | Shares 6,993
Buy 14 May 2020
Value US$15,000.70 | Price 1.43 | Shares 10,490
Buy 14 May 2020
Value US$9,999.99 | Price 1.43 | Shares 6,993
Buy 11 May 2020
Value US$599,999.74 | Price 1.34 | Shares 447,761
Buy 20 Jun 2018
Value US$35,020.00 | Price 0.85 | Shares 41,200
Buy 8 Jun 2018
Value US$8,000.00 | Price 0.80 | Shares 10,000
Buy 8 Jun 2018
Value US$8,000.00 | Price 0.80 | Shares 10,000
Sale 5 Sep 2017
Value US$5,750.46 | Price 0.69 | Shares 8,334
Buy 19 Dec 2016
Value US$21,000.00 | Price 2.10 | Shares 10,000
Buy 16 Dec 2016
Value US$4,693.50 | Price 2.09 | Shares 2,250
Buy 16 Dec 2016
Value US$5,250.00 | Price 2.10 | Shares 2,500
Buy 16 Dec 2016
Value US$29,932.00 | Price 2.00 | Shares 14,966
Buy 14 Dec 2016
Value US$10,375.00 | Price 2.08 | Shares 5,000
Buy 12 Aug 2015
Value US$60,600.00 | Price 6.06 | Shares 10,000
Buy 12 Aug 2015
Value US$81,450.00 | Price 5.43 | Shares 15,000
Buy 12 Aug 2015
Value US$109,000.00 | Price 5.45 | Shares 20,000
Buy 17 Jul 2015
Value US$1,225,000.00 | Price 8.75 | Shares 140,000
Buy 2 Apr 2015
Value US$2,070,000.00 | Price 6.90 | Shares 300,000
Buy 27 Feb 2015
Value US$445,907.66 | Price 5.62 | Shares 79,343
Buy 26 Feb 2015
Value US$427,101.42 | Price 5.42 | Shares 78,801
Buy 25 Feb 2015
Value US$538,327.04 | Price 5.12 | Shares 105,142
Buy 6 Feb 2015
Value US$1,999,998.00 | Price 4.50 | Shares 444,444
Buy 9 Jun 2014
Value US$24,999.55 | Price 3.95 | Shares 6,329
Sale 3 Sep 2013
Value US$36,288.00 | Price 8.64 | Shares 4,200
Sale 30 Aug 2013
Value US$120,900.00 | Price 8.06 | Shares 15,000
Buy 30 Nov 2012
Value US$120,500.00 | Price 4.82 | Shares 25,000
Buy 20 Aug 2012
Value US$17,700.00 | Price 2.36 | Shares 7,500
Buy 17 Aug 2012
Value US$645.00 | Price 2.15 | Shares 300
Buy 16 Aug 2012
Value US$33,631.50 | Price 2.24 | Shares 15,000
Buy 13 Apr 2012
Value US$200,000.00 | Price 0.50 | Shares 400,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-22 2026-06-18 B Purchase
4.1
PACE GARY W
Non-Executive Director
64,010 -17.2%
481.48
US$137,967 		64,010 -17.2% 481.48 US$137,967
2026-06-22 2026-06-18 B Purchase
4.1
PACE GARY W
Non-Executive Director
4,876 +23.9%
17.61
US$3,929,875 		4,876 +23.9% 17.61 US$3,929,875
2026-06-22 2026-06-18 B Purchase
Mohindru Mani

Chief Executive Officer

Executive Director
13,864 +14.8%
190.22
US$2,119,883 		13,864 +14.8% 190.22 US$2,119,883
2025-07-31 2025-07-30 B Purchase
4.1
PACE GARY W
Non-Executive Director
15,000 +1.1%
2.45
US$36,750 		15,000 +1.1% 2.45 US$36,750
2025-07-31 2025-07-30 B Purchase
4.1
PACE GARY W
Non-Executive Director
275,000 +26.0%
2.45
US$673,750 		275,000 +26.0% 2.45 US$673,750
2024-12-18 2024-12-18 B Purchase
3.3
Levine James E.

Chief Financial Officer

Officer
2,400 +3.7%
5.00
US$12,000 		2,400 +3.7% 5.00 US$12,000
2024-12-18 2024-12-17 B Purchase
3.3
Levine James E.

Chief Financial Officer

Officer
2,752 +4.4%
5.42
US$14,905 		2,752 +4.4% 5.42 US$14,905
2024-12-18 2024-12-16 B Purchase
3.3
Levine James E.

Chief Financial Officer

Officer
2,564 +4.3%
3.83
US$9,820 		2,564 +4.3% 3.83 US$9,820
2024-12-16 2024-12-12 B Purchase
3.4
TANNENBAUM RENEE P
Non-Executive Director
10,000 +100.0%
3.42
US$34,224 		10,000 +100.0% 3.42 US$34,224
2024-12-12 2024-12-11 B Purchase
4.1
PACE GARY W
Non-Executive Director
11,500 +1.1%
2.60
US$29,900 		11,500 +1.1% 2.60 US$29,900
2024-12-12 2024-12-11 B Purchase
4.1
PACE GARY W
Non-Executive Director
350,115 +50.2%
2.60
US$910,299 		350,115 +50.2% 2.60 US$910,299
2023-12-19 2023-12-19 B Purchase
4.1
PACE GARY W
Non-Executive Director
30,000 +4.5%
1.37
US$41,100 		30,000 +4.5% 1.37 US$41,100
2023-11-14 2023-11-10 B Purchase
4.1
PACE GARY W
Non-Executive Director
22,950 +3.6%
0.98
US$22,491 		22,950 +3.6% 0.98 US$22,491
2022-11-29 2022-11-25 B Purchase
3.5
Erlander Mark

Chief Executive Officer

Executive Director
10,000 +69.1%
1.43
US$14,300 		10,000 +69.1% 1.43 US$14,300
2022-09-20 2022-09-19 B Purchase
3.6
White Lale
Non-Executive Director
15,000 +15.2%
1.64
US$24,525 		15,000 +15.2% 1.64 US$24,525
2022-10-11 2022-09-16 B Purchase
2.9
Armitage James O
Non-Executive Director
13,000 +inf%
1.56
US$20,233 		13,000 +inf% 1.56 US$20,233
2022-09-19 2022-09-16 B Purchase
3.3
Levine James E.

Chief Financial Officer

Officer
30,000 +100.0%
1.56
US$46,710 		30,000 +100.0% 1.56 US$46,710
2022-09-19 2022-09-15 B Purchase
3.4
TANNENBAUM RENEE P
Non-Executive Director
3,600 +56.2%
1.72
US$6,192 		3,600 +56.2% 1.72 US$6,192
2022-09-19 2022-09-15 B Purchase
3.4
TANNENBAUM RENEE P
Non-Executive Director
6,400 +inf%
1.72
US$10,976 		6,400 +inf% 1.72 US$10,976
2022-09-19 2022-09-15 B Purchase
4.1
PACE GARY W
Non-Executive Director
150,000 +30.3%
1.71
US$256,500 		150,000 +30.3% 1.71 US$256,500
2021-09-13 2021-09-10 B Purchase
3.3
Levine James E.

Chief Financial Officer

Officer
5,000 +20.0%
6.32
US$31,600 		5,000 +20.0% 6.32 US$31,600
2021-09-13 2021-09-10 B Purchase
3.3
Levine James E.

Chief Financial Officer

Officer
5,000 +25.0%
6.35
US$31,750 		5,000 +25.0% 6.35 US$31,750
2021-09-13 2021-09-10 B Purchase
3.3
Levine James E.

Chief Financial Officer

Officer
10,000 +100.0%
6.38
US$63,800 		10,000 +100.0% 6.38 US$63,800
2021-09-13 2021-09-10 B Purchase
3.3
Levine James E.

Chief Financial Officer

Officer
5,000 +100.0%
6.75
US$33,750 		5,000 +100.0% 6.75 US$33,750
2021-09-13 2021-09-10 B Purchase
3.3
Levine James E.

Chief Financial Officer

Officer
5,000 +inf%
6.62
US$33,100 		5,000 +inf% 6.62 US$33,100
2021-03-29 2021-03-26 B Purchase
3.2
Markin Rodney S
Non-Executive Director
2,900 +13.8%
10.32
US$29,933 		2,900 +13.8% 10.32 US$29,933
2021-03-24 2021-03-23 B Purchase
4.1
PACE GARY W
Non-Executive Director
2,500 +0.5%
10.31
US$25,775 		2,500 +0.5% 10.31 US$25,775
2021-03-24 2021-03-23 B Purchase
4.1
PACE GARY W
Non-Executive Director
2,500 +0.5%
10.21
US$25,525 		2,500 +0.5% 10.21 US$25,525
2021-03-24 2021-03-23 B Purchase
4.1
PACE GARY W
Non-Executive Director
5,000 +1.1%
10.20
US$51,000 		5,000 +1.1% 10.20 US$51,000
2021-03-23 2021-03-23 B Purchase
3.5
Erlander Mark

Chief Executive Officer

Officer
965 +7.1%
10.34
US$9,980 		965 +7.1% 10.34 US$9,980
2021-03-23 2021-03-23 B Purchase
3.6
JACOB GARY S
Non-Executive Director
470 +2.2%
10.40
US$4,886 		470 +2.2% 10.40 US$4,886
2021-03-23 2021-03-23 B Purchase
3.6
JACOB GARY S
Non-Executive Director
1,900 +9.7%
10.42
US$19,804 		1,900 +9.7% 10.42 US$19,804
2021-03-23 2021-03-23 B Purchase
2.8
Kelemen Vicki

Exec. VP and COO

Officer
960 +18.8%
10.31
US$9,898 		960 +18.8% 10.31 US$9,898
2021-03-22 2021-03-22 B Purchase
3.2
BRANCACCIO JOHN P
Non-Executive Director
3,000 +32.4%
10.95
US$32,850 		3,000 +32.4% 10.95 US$32,850
2021-05-27 2021-03-19 B Purchase
2.9
Armitage James O
Non-Executive Director
4,000 +38.1%
10.82
US$43,271 		4,000 +38.1% 10.82 US$43,271
2021-03-19 2021-03-18 B Purchase
4.1
PACE GARY W
Non-Executive Director
2,000 +0.4%
10.54
US$21,080 		2,000 +0.4% 10.54 US$21,080
2021-03-19 2021-03-18 B Purchase
4.1
PACE GARY W
Non-Executive Director
1,000 +0.2%
10.58
US$10,580 		1,000 +0.2% 10.58 US$10,580
2021-03-04 2021-03-04 B Purchase
4.1
PACE GARY W
Non-Executive Director
1,500 +0.3%
9.27
US$13,898 		1,500 +0.3% 9.27 US$13,898
2020-11-25 2020-11-23 S Sale
2.8
Kelemen Vicki

Exec. VP and COO

Officer
35,321 -87.5%
18.60
US$657,020 		35,321 -87.5% 18.60 US$657,020
2020-09-17 2020-09-16 B Purchase
4.1
PACE GARY W
Non-Executive Director
850 +0.2%
5.71
US$4,854 		850 +0.2% 5.71 US$4,854
2020-09-17 2020-09-16 B Purchase
4.1
PACE GARY W
Non-Executive Director
1,700 +0.4%
5.69
US$9,673 		1,700 +0.4% 5.69 US$9,673
2020-05-18 2020-05-14 B Purchase
3.6
JACOB GARY S
Non-Executive Director
17,483 +845.0%
1.43
US$25,001 		17,483 +845.0% 1.43 US$25,001
2020-05-18 2020-05-14 B Purchase
3.2
Markin Rodney S
Non-Executive Director
20,979 +292.1%
1.43
US$30,000 		20,979 +292.1% 1.43 US$30,000
2020-05-18 2020-05-14 B Purchase
3.6
White Lale
Non-Executive Director
69,930 +inf%
1.43
US$100,000 		69,930 +inf% 1.43 US$100,000
2020-05-18 2020-05-14 B Purchase
3.4
ADAMS THOMAS PHD
Non-Executive Director
13,986 +286.1%
1.43
US$20,000 		13,986 +286.1% 1.43 US$20,000
2020-05-18 2020-05-14 B Purchase
3.5
Erlander Mark

Chief Executive Officer

Officer
6,993 +109.7%
1.43
US$10,000 		6,993 +109.7% 1.43 US$10,000
2020-05-18 2020-05-14 B Purchase
2.9
Armitage James O
Non-Executive Director
10,490 +inf%
1.43
US$15,001 		10,490 +inf% 1.43 US$15,001
2020-05-18 2020-05-14 B Purchase
3.2
BRANCACCIO JOHN P
Non-Executive Director
6,993 +308.5%
1.43
US$10,000 		6,993 +308.5% 1.43 US$10,000
2020-05-13 2020-05-11 B Purchase
4.1
PACE GARY W
Non-Executive Director
447,761 +inf%
1.34
US$600,000 		447,761 +inf% 1.34 US$600,000
2018-06-21 2018-06-20 B Purchase Markin Rodney S
41,200 +182.2%
0.85
US$35,020 		41,200 +182.2% 0.85 US$35,020
2018-06-11 2018-06-08 B Purchase BRANCACCIO JOHN P
10,000 +23.2%
0.80
US$8,000 		10,000 +23.2% 0.80 US$8,000
2018-06-11 2018-06-08 B Purchase Tennant Stanley
10,000 +4.4%
0.80
US$8,000 		10,000 +4.4% 0.80 US$8,000
2017-09-06 2017-09-05 S Sale Tennant Stanley
8,334 -3.8%
0.69
US$5,750 		8,334 -3.8% 0.69 US$5,750
2016-12-19 2016-12-19 B Purchase Tennant Stanley Non-Executive Director
10,000 +4.8%
2.10
US$21,000 		10,000 +4.8% 2.10 US$21,000
2016-12-19 2016-12-16 B Purchase WELCH WILLIAM J

CEO

Executive Director
2,250 +90.0%
2.09
US$4,694 		2,250 +90.0% 2.09 US$4,694
2016-12-19 2016-12-16 B Purchase WELCH WILLIAM J

CEO

Executive Director
2,500 +inf%
2.10
US$5,250 		2,500 +inf% 2.10 US$5,250
2016-12-19 2016-12-16 B Purchase Tennant Stanley Non-Executive Director
14,966 +7.8%
2.00
US$29,932 		14,966 +7.8% 2.00 US$29,932
2016-12-15 2016-12-14 B Purchase Erlander Mark

Chief Scientific Officer

Officer
5,000 +inf%
2.08
US$10,375 		5,000 +inf% 2.08 US$10,375
2015-08-12 2015-08-12 B Purchase Tennant Stanley Non-Executive Director
10,000 +5.5%
6.06
US$60,600 		10,000 +5.5% 6.06 US$60,600
2015-08-12 2015-08-12 B Purchase ZANIBONI STEVE

CFO

Officer
15,000 +237.0%
5.43
US$81,450 		15,000 +237.0% 5.43 US$81,450
2015-08-12 2015-08-12 B Purchase SCHUH ANTONIUS

CEO

Executive Director
20,000 +inf%
5.45
US$109,000 		20,000 +inf% 5.45 US$109,000
2015-07-21 2015-07-17 B Purchase BRIDGER MANAGEMENT, LLC Large shareholder
140,000 +4.4%
8.75
US$1,225,000 		140,000 +4.4% 8.75 US$1,225,000
2015-04-06 2015-04-02 B Purchase BRIDGER MANAGEMENT, LLC Large shareholder
300,000 +10.5%
6.90
US$2,070,000 		300,000 +10.5% 6.90 US$2,070,000
2015-02-27 2015-02-27 B Purchase BRIDGER MANAGEMENT, LLC Large shareholder
79,343 +2.9%
5.62
US$445,908 		79,343 +2.9% 5.62 US$445,908
2015-02-27 2015-02-26 B Purchase BRIDGER MANAGEMENT, LLC Large shareholder
78,801 +2.9%
5.42
US$427,101 		78,801 +2.9% 5.42 US$427,101
2015-02-27 2015-02-25 B Purchase BRIDGER MANAGEMENT, LLC Large shareholder
105,142 +4.1%
5.12
US$538,327 		105,142 +4.1% 5.12 US$538,327
2015-02-10 2015-02-06 B Purchase BRIDGER MANAGEMENT, LLC Large shareholder
444,444 +20.7%
4.50
US$1,999,998 		444,444 +20.7% 4.50 US$1,999,998
2014-06-10 2014-06-09 B Purchase ZANIBONI STEVE

CFO

Officer
6,329 +inf%
3.95
US$25,000 		6,329 +inf% 3.95 US$25,000
2013-09-04 2013-09-03 S Sale ADAMS THOMAS PHD Non-Executive Director
4,200 -1.3%
8.64
US$36,288 		4,200 -1.3% 8.64 US$36,288
2013-09-04 2013-08-30 S Sale ADAMS THOMAS PHD
15,000 -4.3%
8.06
US$120,900 		15,000 -4.3% 8.06 US$120,900
2012-12-03 2012-11-30 B Purchase Tennant Stanley Non-Executive Director
25,000 +18.4%
4.82
US$120,500 		25,000 +18.4% 4.82 US$120,500
2012-08-20 2012-08-20 B Purchase CERRONE GABRIEL Non-Executive Director
7,500 +1.1%
2.36
US$17,700 		7,500 +1.1% 2.36 US$17,700
2012-08-20 2012-08-17 B Purchase CERRONE GABRIEL Non-Executive Director
300 +0.0%
2.15
US$645 		300 +0.0% 2.15 US$645
2012-08-17 2012-08-16 B Purchase CERRONE GABRIEL Non-Executive Director
15,000 +2.3%
2.24
US$33,632 		15,000 +2.3% 2.24 US$33,632
2012-04-16 2012-04-13 B Purchase Hunter Robert Merrill Large shareholder
400,000 +8.6%
0.50
US$200,000 		400,000 +8.6% 0.50 US$200,000
Explore more

More insider trading research around Cardiff Oncology Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America